The spreading of pathological alpha-synuclein through the brain in PD largely follows a defined staging pattern from brainstem through to neocortical regions, associating with an array of clinical symptoms including autonomic dysfunction, REM sleep disorder, depression and cognitive decline2,3. This evidence concerns the gene SNCA and Parkinson disease.